Clover Health Investments, Corp. (CLOV) - Stock Analysis

Last updated: May 10, 2026

HealthcareActive

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.

Loading chart data...

Idea window: 5/7/2026 – 5/14/2026Sector: Healthcare

AI Analyst Overview

Last Price
$3.28
Market Cap
$1.66B
1D Return
+2.50%
YTD Return
+39.57%

Loading chart data...

Valuation Metrics

P/E
-29.4
P/B
4.9
P/S
0.8
EV/EBITDA
-30.0
Div Yield
—

Fundamental Analysis

Key Financial Insights: • Profitability rebound • Strong cash flow • Rising liabilities CLOV's latest quarter shows a meaningful turnaround, with net income, margins, and cash flow all improving sharply, but rising liabilities and a still-elevated price-to-book keep the outlook mixed.

turnaround
watchlist

Price Behavior

Key Price Behavior Insights: • Higher highs • Resistance breakout • Stretch risk Support Level: $2.68-$2.71, then $2.58-$2.61 Resistance Level: $2.75-$2.82 CLOV has rallied from $1.93 to $3.12 over the last month, breaking above $2.75-$2.82 resistance and staying in a strong uptrend, though the move is stretched and could retrace if it slips below $2.71 or $2.58.

bullish
breakout

Sentiment & News

Key News Insights: • Revenue growth • Membership gains • Profitability outlook Clover Health delivered a strong Q1 2026 beat with revenue up 62%, Medicare Advantage membership up 51%, and positive GAAP net income, while reaffirming confidence in full-year profitability.

CloverHealth
Earnings
AI

AI Summary

CLOV has shifted from a speculative growth story to a real turnaround only if it can keep converting membership gains into sustained GAAP profitability and positive free cash flow, but the recent breakout already prices in a lot of that progress and leaves the stock vulnerable if medical costs, CMS pressure, or execution slip.

Turnaround
CashFlow
MedicareAdvantage
AI summary updated 3 days ago

Description

Clover Health Investments, Corp. is a U.S. insurer that offers Medicare Advantage products to eligible beneficiaries, delivering plan administration through its Clover Assistant software platform and operating both PPO and HMO plan types. The company also conducts non-insurance activities alongside its core insurance business. Founded in 2014, Clover Health is headquartered in Franklin, Tennessee.

Idea History

DateCloseTickerCompanySummaryStatusP/L
May 7May 14CLOVClover Health Investments, Corp.
Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.
Active+16.3%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.